Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide

Tools
- Tools
+ Tools

Yamin, Rina, Zhao, Cheng, O'Connor, Peter B., McKee, Ann C. and Abraham, Carmela R.. (2009) Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide. Molecular Neurodegeneration, Vol.4 (No.1). Article: 33. ISSN 1750-1326

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1186/1750-1326-4-33

Abstract

The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of neurons in the Alzheimer's disease brain. Amyloid-beta exists in different assembly forms in the aging mammalian brain including monomers, oligomers, and aggregates, and in senile plaques, fibrils. Recent findings suggest that soluble amyloid-beta oligomers may represent the primary pathological species in Alzheimer's disease and the most toxic form that impairs synaptic and thus neuronal function. We previously reported the isolation of a novel amyloid-beta-degrading enzyme, acyl peptide hydrolase, a serine protease that degrades amyloid-beta, and is different in structure and activity from other amyloid-beta-degrading enzymes.

Item Type: Journal Article
Subjects: Q Science > QD Chemistry
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Divisions: Faculty of Science > Chemistry
Library of Congress Subject Headings (LCSH): Amyloid beta-protein, Hydrolases, Alzheimer's disease -- Etiology, Neurotoxicology, Peptides, Mass spectrometry
Journal or Publication Title: Molecular Neurodegeneration
Publisher: BioMed Central Ltd.
ISSN: 1750-1326
Date: 2009
Volume: Vol.4
Number: No.1
Number of Pages: 10
Page Range: Article: 33
Identification Number: 10.1186/1750-1326-4-33
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access
Funder: Alzheimer's Association, National Institutes of Health (U.S.) (NIH), National Institute on Aging (NIA), Boston University. Alzheimer's Disease Centre (ADC), United States. Department of Veterans Affairs
Grant number: IIRG-02-3783 (AA), P01-AG00001 (NIA), NIA P30 AG13846 (ADC)
URI: http://wrap.warwick.ac.uk/id/eprint/40607

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us